What question did this study set out to answer?

To review modern molecular engineering and rational design strategies used to generate synthetic antibodies for clinical diagnostic and therapeutic use.

June 15, 2009Acta NaturaeOpen Access

Modern Technologies for Creating Synthetic Antibodies for Clinical Application

View Full Paper

Ask AI

Bookmark

Authors

SDSergey M. Deyev ЕЛЕ. Н. Лебеденко

Discussion

Member takes

Overview

Review outlines advances in antibody engineering for clinical diagnostics and therapy, highlighting strategies to optimize specificity and effector functions.

Key Points

To review modern molecular engineering and rational design strategies used to generate synthetic antibodies for clinical diagnostic and therapeutic use.
Synthesized molecular engineering technologies focused on modifying immunoglobulin structural domains, size, affinity, and specificity.
Assessed methodologies for altering antibody effector functions and integrating functional modules such as the barnase:barstar system.
Rational protein engineering enables directional optimization of antibody pharmacokinetics, biodistribution, and effector responses, including complement-dependent and cellular cytotoxicity.
Modular antibody platforms, such as single-chain variable fragments and multivalent or bispecific constructs, improve target-specific delivery of diagnostic and therapeutic agents.

Cite This Study

Deyev et al. (2009) studied this question.

synapsesocial.com/papers/6a8074bf9127ec26133d2dde https://doi.org/10.32607/20758251-2009-1-1-32-50

View Full Paper

Ask AI

Bookmark

June 15, 2009Acta NaturaeOpen Access

Modern Technologies for Creating Synthetic Antibodies for Clinical Application

View Full Paper

Ask AI

Bookmark

Authors

SDSergey M. Deyev ЕЛЕ. Н. Лебеденко

Discussion

Member takes

Overview

Review outlines advances in antibody engineering for clinical diagnostics and therapy, highlighting strategies to optimize specificity and effector functions.

Key Points

To review modern molecular engineering and rational design strategies used to generate synthetic antibodies for clinical diagnostic and therapeutic use.
Synthesized molecular engineering technologies focused on modifying immunoglobulin structural domains, size, affinity, and specificity.
Assessed methodologies for altering antibody effector functions and integrating functional modules such as the barnase:barstar system.
Rational protein engineering enables directional optimization of antibody pharmacokinetics, biodistribution, and effector responses, including complement-dependent and cellular cytotoxicity.
Modular antibody platforms, such as single-chain variable fragments and multivalent or bispecific constructs, improve target-specific delivery of diagnostic and therapeutic agents.

Cite This Study

Deyev et al. (2009) studied this question.

synapsesocial.com/papers/6a8074bf9127ec26133d2dde https://doi.org/10.32607/20758251-2009-1-1-32-50

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark